Oesophageal Cancer Clinical Trials
Oesophageal cancer is one of the rarer types of cancer, with over 500,000 new cases diagnosed in 2022. However, it is an important disease we need to understand and learn to tackle more effectively to improve patient standard of care, survival rates, and quality of life.
Thanks to clinical trials for oesophageal cancer, we can better understand the disease and its intricacies and get a step closer to developing more effective treatment options for the patients of today and the future.
Clinical Net plays a vital role in this as we aim to connect eligible patients with suitable clinical trials easily, quickly and completely for free. In the sections below, we’ve provided you with essential information about clinical trials for oesophageal cancer, including:
- The benefits of participating
- What you can expect
- The eligibility criteria
- Risks and considerations
- Clinical Net’s role in these clinical studies
Table of Contents
What are Clinical Trials?
A clinical trial is a controlled and highly regulated study that evaluates the safety and efficacy of medical interventions, medicines or medical devices.
Clinical trials are essential for developing new treatments for oesophageal and other types of cancer. They allow us to rigorously test the safety and effectiveness of new treatments and interventions.
Benefits of Participating in Oesophageal Clinical Trials
There are a number of benefits to participating in a clinical trial for oesophageal cancer. Some of the main benefits include:
Access to New Treatment Options
Patients who decide to participate in a clinical trial for oesophageal cancer will get access to newly developed treatment options that are not yet available to the public. This is one of the biggest personal benefits for those who have undergone a standard oesophageal cancer treatment without much success or those looking to try a new treatment.
Receive Higher Levels of Monitoring and Care
If you choose to participate in a clinical trial for oesophageal cancer, you will receive dedicated medical care and close monitoring. Participants in clinical trials often receive a higher level of medical care and attention compared to routine treatment, including frequent check-ups, comprehensive screening, and access to specialists at no cost.
Contribute to Advancing New Treatments
Aside from the personal benefits, participating in a clinical trial means contributing to the development of more effective treatments for oesophageal cancer.
While doctors, scientists, and sponsors in clinical trial studies all play crucial roles in developing new and more effective treatment options for oesophageal cancer, none of the progress being made would be possible without the participation of cancer patients.
It’s thanks to the tens of thousands of oesophageal cancer patients who have participated in clinical studies that progress has been made in the fight against this disease.
How Oesophageal Cancer Clinical Trials Work
This section describes the phases of clinical trials, patient eligibility, and the informed consent process you’ll have to go through before participating.
Phases of Clinical Trials (Phase I, II, III, IV)
Clinical trials for oesophageal cancer are split into four different phases, each of which has specific objectives. Here is a brief overview of what each clinical trial phase looks like:
- Phase I: These trials involve a small number of participants, usually less than 100. Phase I clinical trials evaluate the overall safety of a new treatment, determine the proper dosage, and compare routes of administration while monitoring for potential side effects.
- Phase II: Treatments that are decided to be safe and show a positive response are taken to Phase II to evaluate their effectiveness and further check for risks and side effects. Treatments that make it to Phase II are often administered to a larger number of people.
- Phase III: In Phase III, the new treatments are administered to even more people. The new treatment’s response, effectiveness, and safety are then compared to current therapies.
- Phase IV: Once a treatment is approved and available to the wider public, it can be evaluated in a Phase IV trial. This trial focuses on the longer-term safety and effectiveness of the treatment as it is distributed to a wider and more diverse population.
Eligibility Criteria for Oesophageal Cancer Clinical Trials
Every clinical trial for oesophageal cancer has its own eligibility criteria that candidates need to meet to be eligible for participation. The exact eligibility criteria will be determined based on factors such as the specific objectives of the trial, the type and stage of oesophageal cancer being studied, the treatment methods being tested, and more.
To simplify the participant eligibility process, when you use the Clinical Net platform, based on your input, we will automatically filter out all of the oesophageal cancer trials that you’re not eligible for and will display only the ones that are relevant to you.
Informed Consent Process
Before participating in a clinical trial, you will be familiarised with all of the information and details around the trial, including the procedures that will take place, the potential side effects that you can expect, the potential benefits, and more.
This is also when you can ask the doctors working on the trial any questions you might have. Once you’ve reviewed everything you need to know, you’ll be asked to sign a consent form if you are still interested in participating in the clinical trial.
Advancements Due to Oesophageal Cancer Clinical Trials
Targeted Therapies
Targeted therapies are designed to attack specific mutations or changes in cancer cells that enable them to grow and multiply. This means the drug focuses on killing these cancer cells while minimising damage to healthy cells.
Targeted therapies being used to treat oesophageal cancer include new drugs targeting HER2 (Human Endothelial Growth factor Receptor 2), VEGF (Vascular Endothelial Growth Factor), and NTRK (Neurotrophic Tyrosine Receptor Kinase) inhibitors. Some targeted therapies include small molecules and antibody-drug conjugates (ADCs).
Immunotherapy
Immunotherapies like PD-1 and CTLA-4 checkpoint inhibitors may help treat some oesophageal cancers. Cancer cells often use ‘checkpoints,’ specific proteins in the body that prevent it from attacking its own cells, to avoid detection and multiply. These drugs block these proteins, enabling the immune system to detect and attack the cancer cells.
Minimally-Invasive Detection
In recent years, a quicker, more comfortable system has been developed for oesophageal cancer screening. EsoCheck can be used for targeted sampling and biomarker testing. With EsoCheck, samples can be collected in about five minutes without endoscopy or anaesthesia.
How Can I Find Clinical Trials for Oesophageal Cancer I May Be Eligible For?
You can find suitable clinical trials for oesophageal cancer on the Clinical Net website. To get matched with a clinical trial that you’re eligible for, please follow these guidelines:
Provide General Information
To match you with suitable clinical trials for oesophageal cancer, you need to go to the ‘Match’ section of trials.clinicalnet.com and answer some questions about you, your diagnosis, and/or your treatments, if you have had any. Then, based on your input, the Clinical Net platform will automatically narrow down the selection of clinical trials for oesophageal cancer for which you are eligible.
Get Connected With Your Clinical Trial
Once you meet the eligibility criteria of a particular clinical trial by at least 40%, you can click ‘Connect’ to that trial. You will then be put in touch with the clinical trial team. They will give you more information about the trial, which will help you decide if you want to participate in it.
Risks and Considerations
It’s important to be aware of the potential risks that you may be exposed to while undergoing a clinical trial treatment for oesophageal cancer. This will help you make the right decisions. Some examples to be aware of include:
- Potential side effects and risks of new treatments
- How the clinical trial may affect your current treatment
- The emotional and psychological impact of undergoing a clinical trial
- You will have to give informed consent before participating in a trial
- The trial protocol requirements that you need to adhere to (treatments, follow-up visits, data collection, and more).
Potential side effects from the new treatment are a common concern for individuals considering participation in clinical trials. However, it’s important to note that clinical trial participants are closely monitored, and any side effects are typically identified and addressed promptly. Additionally, participants can withdraw from the trial at any time.
The Role of Clinical Net in Oesophageal Cancer Clinical Trials
Clinical Net was founded to make clinical trials not only more accessible to patients but also help organisers recruit participants faster and more efficiently. That way, patients could easily take advantage of new treatments years before these are available in hospitals by getting matched with a suitable clinical trial. At the same time, organisers could test and develop new treatments significantly faster. Some other reasons why you should choose Clinical Net include:
- Through Clinical Net, you can access over 75,000 ongoing clinical trials
- It can match and connect you to a suitable clinical trial in less than five minutes
- Finding and getting matched with a clinical trial is completely free
FAQs About Oesophageal Cancer Clinical Trials
Where Can I Find More Information About Colon Cancer Clinical Trials and Resources for Patients?
The Clinical Net website provides more information and resources about cancer clinical trials. We have a database of over 480,000 clinical trials from all around the world, including those focusing on colon cancer.
Can I Participate in an Oesophageal Cancer Clinical Trial if I Have Already Received Treatment for Oesophageal Cancer?
Yes, you can. Your suitability for a particular oesophageal cancer clinical trial will depend on the clinical trial itself, the treatment that you have received, and various other factors such as your age, gender, overall well-being, and more.
What Should I Expect During an Oesophageal Cancer Clinical Trial?
Every oesophageal cancer trial follows a different process, which is largely affected by the objective of the trial and the protocol that must be followed. That being said, cancer trials follow a similar framework, which looks something like this:
- Screening and enrollment
- Allocation of treatment
- Administration of treatment
- Follow-up appointments
- Collection of data
- Adherence to protocol
- Access to support services
Can I Leave an Oesophageal Cancer Clinical Trial if I Change My Mind or Experience Adverse Effects?
Yes, you can. Although you’ll always be asked to sign a consent form before starting treatment, whether you experience adverse effects or simply change your mind and wish to stop, you can do so, and it will not affect your ongoing medical care.
Will I Still Receive Standard Care While Participating in an Oesophageal Cancer Clinical Trial?
Participating in an oesophageal cancer clinical trial does not mean you will be deprived of standard care. Clinical trials are designed to compare new treatments to the current best standard of care, not to withhold treatment. When you participate in a trial:
- You will receive at least the standard treatment for your type and stage of oesophageal cancer.
- The trial may provide additional or newer treatments on top of standard care.
- Your care will be closely monitored by both your regular cancer team and the research team.
Are There Costs Associated With Participating in Oesophageal Cancer Clinical Trials?
No, there are no costs associated with participating in oesophageal cancer research studies. All clinical trials for oesophageal cancer on the Clinical Net website are free and fully funded by the respective research organisation or sponsor.
How Are Oesophageal Cancer Clinical Trials Regulated to Ensure Patient Safety?
Clinical trials are very tightly regulated to ensure patient safety and ethical conduct. To ensure that all clinical trials are conducted properly, there are several regulatory mechanisms in place, including:
- Institutional review boards (IRBs)
- Good clinical practice (GCP)
- Informed consent
- Safety monitoring
- Regulatory agencies such as the FDA in the US, EMA in Europe, and MHRA in the UK